Fate Therapeutics FATE
NASDAQ FATE
$2.37 -0.01 (-0.42%)
At close: Sep 30, 2026 · 4:00 PM EDT

Fate Therapeutics (FATE) Other financing activities (2018 - 2024)

Updated

Fate Therapeutics (FATE) posted Other financing activities of $3.13 million for Q4 2024.

Analysis

Fate Therapeutics (FATE) Other financing activities (2018 - 2024) Analysis & Trends

For FY2024, Fate Therapeutics' Other financing activities came in at $5.07 million.

  • Annual Other financing activities shows a four-year compound annual growth rate of 79.4% (FY2020 to FY2024).
  • In prior years, Fate Therapeutics' Other financing activities was $490,000 in FY2020.
  • The Q4 2024 figure stands as the lowest quarterly Other financing activities since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Fate Therapeutics 277.73 Mn 277.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 3.13 Mn
Dec 31, 2020 50,000.00
Mar 31, 2020 440,000.00
Dec 31, 2018 1.37 Mn
Sep 30, 2018 1.14 Mn
API Access

Fate Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=FATE&period=max&api_key=YOUR_API_KEY